Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

927 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
Zhang M, Ho A, Hammond EH, Suzuki Y, Bermudez RS, Lee RJ, Pilepich M, Shipley WU, Sandler H, Khor LY, Pollack A, Chakravarti A. Zhang M, et al. Among authors: chakravarti a. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1033-42. doi: 10.1016/j.ijrobp.2008.06.1489. Epub 2008 Oct 30. Int J Radiat Oncol Biol Phys. 2009. PMID: 18977097 Free PMC article.
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
Chakravarti A, Winter K, Wu CL, Kaufman D, Hammond E, Parliament M, Tester W, Hagan M, Grignon D, Heney N, Pollack A, Sandler H, Shipley W. Chakravarti A, et al. Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):309-17. doi: 10.1016/j.ijrobp.2004.09.047. Int J Radiat Oncol Biol Phys. 2005. PMID: 15890569
Novel radiation-enhancing agents in malignant gliomas.
Zhang M, Chakravarti A. Zhang M, et al. Among authors: chakravarti a. Semin Radiat Oncol. 2006 Jan;16(1):29-37. doi: 10.1016/j.semradonc.2005.08.004. Semin Radiat Oncol. 2006. PMID: 16378904 Review.
Survivin is a potential mediator of prostate cancer metastasis.
Zhang M, Coen JJ, Suzuki Y, Siedow MR, Niemierko A, Khor LY, Pollack A, Zhang Y, Zietman AL, Shipley WU, Chakravarti A. Zhang M, et al. Among authors: chakravarti a. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1095-103. doi: 10.1016/j.ijrobp.2009.09.007. Epub 2010 Mar 16. Int J Radiat Oncol Biol Phys. 2010. PMID: 20231071 Free PMC article.
MicroRNA Biomarkers for Patients With Muscle-Invasive Bladder Cancer Undergoing Selective Bladder-Sparing Trimodality Treatment.
Meng W, Efstathiou J, Singh R, McElroy J, Volinia S, Cui R, Ibrahim A, Johnson B, Gupta N, Mehta S, Wang H, Miller E, Nguyen P, Fleming J, Wu CL, Haque SJ, Shipley W, Chakravarti A. Meng W, et al. Among authors: chakravarti a. Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):197-206. doi: 10.1016/j.ijrobp.2018.12.028. Epub 2018 Dec 21. Int J Radiat Oncol Biol Phys. 2019. PMID: 30583038
Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10.
Chakravarti A, Heydon K, Wu CL, Hammond E, Pollack A, Roach M, Wolkov H, Okunieff P, Cox J, Fontanesi J, Abrams R, Pilepich M, Shipley W; Radiation Therapy Oncology Group. Chakravarti A, et al. J Clin Oncol. 2003 Sep 1;21(17):3328-34. doi: 10.1200/JCO.2003.12.151. J Clin Oncol. 2003. PMID: 12947069
927 results